# Combined Behavioral and Drug Treatment of Overactive Bladder in Men

> **NCT01175382** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 204 (actual)

## Conditions studied

- Overactive Bladder
- Lower Urinary Tract Symptoms

## Interventions

- **BEHAVIORAL:** Behavioral training
- **DRUG:** Tolterodine + tamsulosin
- **OTHER:** Combined Behavioral + Drug Therapy

## Key facts

- **NCT ID:** NCT01175382
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175382, "Combined Behavioral and Drug Treatment of Overactive Bladder in Men". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01175382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*